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Abstract objective To determine the causative agents of infections and their antimicrobial susceptibility at a
tertiary care hospital in Moshi, Tanzania, to guide optimal treatment.
methods A total of 590 specimens (stool (56), sputum (122), blood (126) and wound swabs (286))
were collected from 575 patients admitted in the medical and surgical departments. The bacterial
species were determined by conventional methods, and disc diffusion was used to determine the
antimicrobial susceptibility pattern of the bacterial isolates.
results A total of 249 (42.2%) specimens were culture-positive yielding a total of 377 isolates. A
wide range of bacteria was isolated, the most predominant being Gram-negative bacteria: Proteus
spp. (n = 48, 12.7%), Escherichia coli (n = 44, 11.7%), Pseudomonas spp. (n = 40, 10.6%) and
Klebsiella spp (n = 38, 10.1%). Wound infections were characterised by multiple isolates (n = 293,
77.7%), with the most frequent being Proteus spp. (n = 44, 15%), Pseudomonas (n = 37, 12.6%),
Staphylococcus (n = 29, 9.9%) and Klebsiella spp. (n = 28, 9.6%). All Staphylococcus aureus tested
were resistant to penicillin (n = 22, 100%) and susceptible to vancomycin. Significant resistance to
cephalosporins such as cefazolin (n = 62, 72.9%), ceftriaxone (n = 44, 51.8%) and ceftazidime
(n = 40, 37.4%) was observed in Gram-negative bacteria, as well as resistance to cefoxitin (n = 6,
27.3%) in S. aureus.
conclusion The study has revealed a wide range of causative agents, with an alarming rate of
resistance to the commonly used antimicrobial agents. Furthermore, the bacterial spectrum differs
from those often observed in high-income countries. This highlights the imperative of regular
generation of data on aetiological agents and their antimicrobial susceptibility patterns especially in
infectious disease endemic settings. The key steps would be to ensure the diagnostic capacity at a
sufficient number of sites and implement structures to routinely exchange, compare, analyse and
report data. Sentinel sites (hospitals) across the country (and region) should report on a representative
subset of bacterial species and their susceptibility to drugs at least annually. A central organising
body should collate the data and report to relevant national and international stakeholders.
keywords bacterial infections, antimicrobial resistance, Africa, Western Europe, America
Introduction
Regular review of patterns of infections and their
antibacteriogram is key for empirical treatment, which is
common in resource-poor settings. Over the past
20 years, the pattern of infections and their susceptibility
to antimicrobial agents [1, 2] has changed, likely due to
factors such as increased use of antimicrobial agents [3]
and rising prevalence of diabetes mellitus [4] which due
to socio-demographic changes [1] is becoming a common
comorbid condition for patients admitted due to infection
[5]. Human immunodeficiency virus (HIV) has also chan-
ged the pattern of infections [2]; antiretroviral (ARV)
therapies, which boost the immune status of the patients
infected with HIV [6], may play a role in the susceptibil-
ity to both common and opportunistic infections [7], as
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well as other chronic conditions such as cancer and kid-
ney disease.
In Africa, infectious diseases constitute a much higher
burden in people of all age groups [8–13] than in Europe
and North America. Active surveillance systems on infec-
tious disease control are inadequate in most African
countries [14–17], and the absence of data on disease
causes and the lack of control measures add to the dis-
ease burden [6]. Obtaining adequate and timely data on
infectious diseases in African countries is difficult,
whereas much more data are available from developed
countries. As a result, empirical treatment in Africa
regarding pathogenic bacteria might be based on data
from clinical laboratories in developed countries [18].
The pattern of bacterial infections in Africa differs from
those observed in Western Europe and North America;
hence, empirical treatment should be adjusted to fit the
different need. In Africa, as elsewhere, regular local data
collection about patterns of infections, and their response
to antimicrobial agents, coupled with a long-term com-
mitment to providing adequate health information sys-
tems, is key to effective planning and policy formulation.
The availability of data on disease patterns, etiological
agents and their antimicrobial resistance is a prerequisite
for the establishment of empirical treatment regimens and
for avoiding escalation of the global trend of bacterial
resistance to the current antimicrobial regimens [19–21].
This study was conducted to determine the most fre-
quent bacterial species isolated from samples submitted
for microbiological examinations at a tertiary care hospi-
tal in Moshi, Tanzania. We also determined antimicrobial
susceptibility patterns of the isolates and associated
comorbid conditions.
Materials and methods
Study design, location and sample collection
This study is a descriptive analysis of culture, bacterial
identification and antimicrobial susceptibility testing con-
ducted at Kilimanjaro Christian Medical Centre (KCMC),
which hosts a tertiary healthcare facility for the northern
zone of Tanzania. The study was conducted from August
2013 to August 2015. Clinical samples were collected
from inpatients admitted to the medical or surgical wards
of the hospital. Informed consent was obtained from all
participants. Specimens including stool (56), sputum
(122), blood (56) and wound/pus swabs (286) were col-
lected from 575 patients. Twenty specimens were not
included due to insufficient quantity. Blood, stool or spu-
tum samples were collected if the patient was diagnosed
to have septicemia, diarrhoea or upper respiratory
infection, respectively. Blood samples were also collected
from patients with fever of unknown cause. Wound or
pus swabs were collected from wounds due to burns, sur-
gical procedures, diabetes mellitus, animal bites, motor
traffic accidents and other injuries.
Patient hospital files were used to obtain socio-demo-
graphics and clinical characteristics of the study partici-
pants admitted at KCMC wards. Data were recorded on
designated case report forms (CRFs). All samples were
transported immediately after collection to the Kiliman-
jaro Clinical Research Institute (KCRI), to be processed
by the microbiology unit of the biotechnology laboratory
department.
Culture and identification
Wound/pus swabs and sputum specimens were cultured
onto trypticase soy agar with 5% sheep blood (BD
BBLTM), chocolate agar and McConkey agar plate media
(BD BBLTM) and incubated at 37 °C with 5% CO2 for
18–24 h. Stool samples were cultured onto McConkey
agar and incubated at 37 °C overnight. Blood samples
were collected in 40 ml BD BACTEC standard 10 Aero-
bic/F, followed by incubation in BD BACTEC for a maxi-
mum of 5 days. Gram stain was used to differentiate
Gram-positive and Gram-negative bacteria from culture.
Positive blood cultures were inoculated on blood agar,
chocolate agar and McConkey agar and incubated for
18–24 h at 37 °C with 5% CO2. Bacteria were isolated
from culture by picking single colonies and subculturing
onto purity plate (Blood agar) overnight. From the purity
plate, morphology determination and gram stain was
made followed by microscopic examination.
Based on Gram staining results, Gram-negative bacteria
were identified using API 20E and/or API NE 20
(bioMerieux) for Enterobacteriacae and other non-fasti-
dious Gram-negatives. Catalase and coagulase tests were
used to identify Gram-positive cocci. Optochin suscepti-
bility testing (BD BBL TaxoTM Benex Limited, Shannon
County Clare, Ireland) was used to confirm Streptococcus
pneumoniae, and BD BBL Streptocard  Enzyme Latex
test was used to identify streptococcal group A, B, C, D,
F and G.
Antimicrobial susceptibility testing
Antimicrobial susceptibility testing (AST) was performed
using disc diffusion on M€uller–Hinton II Agar (MHA)
according to Clinical Laboratory Standards Institute
(CLSI, 2013) guidelines. Gram-negative bacterial isolates
were tested for ampicillin 10 lg, amoxicillin-clavulanic
acid 30 lg, cefazolin 30 lg, ceftazidime 30 lg,
© 2017 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 455
Tropical Medicine and International Health volume 22 no 4 pp 454–464 april 2017
H. H. Kumburu et al. Infection patterns, bacterial agents and resistance
ceftriaxone 30 lg, chloramphenicol 30 lg, ciprofloxacin
5 lg, gentamicin 10 lg, nalidixic acid 30 lg and
trimethoprim–sulfamethoxazole 23.75 lg/1.25 lg.
Antimicrobials tested for Gram-positive bacterial isolates
were chloramphenicol, trimethoprim-sulfamethoxazole
(23.75 lg/1.25 lg), erythromycin 15 lg, vancomycin
30 lg, penicillin 10 lg and cefoxitin 30 lg. Interpreta-
tion as susceptible, intermediate resistant and resistant
was performed according to CLSI 2013. Isolates with
intermediate or resistant results were merged into a single
group as resistant during data analysis. Considering inter-
mediate group as resistance can be one of the ways of
sidestepping uncertain therapeutic effects [22].
Data analysis
Data were double-entered in OpenClinica (OpenClinica
LLC, Waltham, MA, USA). Data extracts were exported
to STATA 13 (StataCorp LP, Texas 77845, USA). This
tool was used for all analyses. Proportions of comorbidi-
ties and bacterial isolates were calculated and presented
as column or row percentages.
Results
Characteristics of the study participants
Table 1 summarises characteristics of 575 patients with
different medical conditions enrolled in the study from
August 2013 to August 2015. Five patients were excluded
during analysis due to incomplete patient information.
The median age (IQR) was 43 (30–57) years; 61%
(n = 348) were males, 39% females (n = 227).
Half of the participants were peasants (n = 271,
47.3%), and the predominant education level was primary
education (n = 339, 59%); few participants (n = 34,
5.9%) had tertiary education; 71.9% participants
(n = 412) had a history of receiving antibiotic treatment
prior to admission, and 45.9% of patients were admitted
due to wound infection (n = 263), 14.4% due to pneumo-
nia (n = 81), 10.5% due to tuberculosis (n = 60), 8.03%
due to septicemia (n = 46), 3.5% due to diarrhoea
(n = 20) and 0.7% due to meningitis (n = 4). Coexisting
health conditions were diabetes mellitus (n = 122, 21.3%),
HIV (n = 81, 14.1%) and cancer (n = 52, 9.1%).
Culture results
A total of 590 specimens were cultured: 286 wound
swabs, 126 blood, 122 sputum and 56 stool samples;
42.2% of the cultured specimens had positive growth
after overnight incubation: 72.3% of wound swabs
(n = 180), 14.1% of sputum samples (n = 35), 7.6% of
stools (n = 19) and 6% of blood samples (n = 15).
We obtained 377 bacterial isolates; 43.8% of speci-
mens (n = 109) had more than one isolate, and 77.7% of
isolates (n = 293) were obtained from wound swabs,
11% (n = 4), from sputum, 6.1% (n = 23) from stools
and 4.2% (n = 16) from blood cultures (Table 2).
There was a wide range of bacterial isolates, the major-
ity being Gram-negative isolates, with Proteus spp
(n = 48, 12.7%), E. coli (n = 44, 11.7%), Pseudomonas
spp (n = 40, 10.6%) and Klebsiella spp (n = 38, 10.1%)
being predominant, together accounting for 170 (45.1%)
Table 1 Socio-demographics and clinical characteristics of the
study participants admitted at KCMC (N = 575)
Characteristic n (%)
Median age in years (IQR) 43 (30–57)
Male gender 348 (61%)
Female gender 227 (39%)
Department
Surgical ward 232 (40.5)
Medical ward 277 (48.3)
ICU 49 (8.6)
Paediatric 15 (2.6)
Occupation
Farming 271 (47.3)
Employed 56 (9.8)
Business 121 (20.7)
Other 132 (21.8)
Education
None 130 (22.7)
Primary 339 (59.2)
Secondary 70 (12.2)
Tertiary 34 (5.9)
Marital
Single 179 (31.2)
Married 325 (56.7)
*Widowed 69 (12)
Disease conditions
*Wound 263 (45.9)
Pneumonia 87 (14.4)
Tuberculosis 64 (10.6)
Septicemia 52 (8.6)
Diarrhoea 21 (3.5)
Meningitis 4 (0.7)
Comorbidities
Diabetes 122 (21.3)
HIV 81 (14.1)
Cancer 52 (9.1%)
Treatment prior to admission
Yes 412 (71.9%)
IQR (Interquartile range) ICU, intensive care unit TB, tuberculosis
HIV, human immunodeficiency virus. *Widowed: widowed and
divorced, gender n = 574, age n = 559, the rest n = 573, two
patients had no information, *wound (includes abscess).
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of all isolates. The Gram-positive bacteria were Staphylo-
coccus aureus (n = 35, 9.3%), coagulase negative Staphy-
lococcus spp (n = 25, 6.6%) and Streptococcus spp
(n = 17, 4.5%). Wound infections were characterised by
multiple isolates (n = 293, 77.7%), with the most fre-
quent being Proteus spp (n = 44, 15%), Pseudomonas
(n = 37, 12.6%), Staphylococcus (n = 29, 9.9%) and
Klebsiella spp (n = 28, 9.6%). Streptococcus spp were
the most common finding (n = 9, 20%) in sputum sam-
ples, followed by Klebsiella spp (n = 7, 15.6%). E. coli
(n = 11, 47.8%) was the predominant isolate in stool
samples (Table 2).
Pattern of infections and aetiological agents
Table 3 outlines disease conditions found; wound infection
(n = 277, 45.8%), pneumonia (n = 87, 14.4%), tuberculo-
sis (n = 64, 10.6%), septicemia (n = 52, 8.6%), diarrhoea
(n = 21, 3.5%) and %) and meningitis (n = 4, 0.7%).
S. aureus, Klebsiella spp, Proteus spp, E. coli and Pseu-
domonas spp were the most common bacterial pathogens
isolated from patients with the above disease presentations.
The distribution of these pathogens was diversified in
wound infections. Septic wounds were dominated by
Pseudomonas spp (n = 31, 77.5%), Proteus spp (n = 37,
75.5%), E. coli (n = 24, 54.5%), S. aureus (n = 20,
57.1%) and Klebsiella spp (n = 21, 51.2%). Burn and dia-
betic wounds had more Proteus spp (n = 10 (20.4%) and
n = 15 (30.6%), respectively). Motor traffic and post-
surgical wounds had few bacterial isolates.
Table 4a and b summarise the association between
co-existing health conditions such as diabetes, cancer and
HIV and the burden of commonly isolated bacteria. The
prevalence of Proteus spp, Escherichia coli and Pseu-
domonas spp infections was higher among people with
diabetes and cancer, although the associations were not
statistically significant (P > 0.05). A statistically signifi-
cant independent association was observed between the
prevalence of Pseudomonas spp among HIV-negative
patients (11%) and HIV-positive patients (3%)
(P = 0.03). The prevalence of both Proteus spp (16%)
and Pseudomonas spp (13%) among patients with wound
infection was higher than in patients without (P = 0.03).
Pattern of resistance to antimicrobial agents
About three-quarters of the patients (n = 412, 71.9%)
had a history of antibiotic/antimicrobial treatment before
Table 2 Bacteria isolates obtained from culture-positive specimens
Specimen N (%)
Isolates Total (N) Wound swab Sputum Stool Blood
Gram-neg rods 61 52 (85.2) 6 (9.8) 2 (3.3) 1 (1.6)
Proteus spp 48 44 (91.7) 0 (0) 2 (4.2) 2 (4.2)
Escherichia spp 44 24 (54.5) 5 (11.4) 11 (25) 4 (9.1)
Pseudomonas spp 40 37 (92.5) 3 (7.5) 0 (0) 0 (0)
Klebsiella spp 38 28 (73) 7 (18.4) 3 (7.9) 0 (0)
Staphylococcus aureus 35 29 (82.9) 2 (5.7) 0 (0) 4 (11.4)
CoN Staphylococcus 25 18 (72) 2 (8) 2 (8) 3 (12)
Unknown 22 17 (77.3) 4 (18.2) 1 (4.5) 0 (0)
Streptococcus spp 17 7 (41.2) 9 (52.9) 0 (0) 1 (5.9)
Enterobacter spp 15 12 (80) 2 (13.3) 1 (6.7) 0 (0)
Bacillus spp 8 7 (87.5) 0 (0) 0 (0) 1 (0)
Acinetobacter spp 5 3 (60) 2 (40) 0 (0) 0 (0)
Serratia spp 4 2 (50) 1 (25) 1 (25) 0 (0)
Providentia spp 4 4 (100) 0 (0) 0 (0) 0 (0)
Enterococcus spp 3 3 (100) 0 (0) 0 (0) 0 (0)
Gram-positive cocci 2 1 (50) 1 (50) 0 (0) 0 (0)
Diphtheroids spp 2 1 (50) 1 (50) 0 (0) 0 (0)
Stenotrophomonas spp 1 1 (100) 0 (0) 0 (0) 0 (0)
Morganella spp 1 1 (100) 0 (0) 0 (0) 0 (0)
Citrobacter spp 1 1 (100) 0 (0) 0 (0) 0 (0)
Aeromonas spp 1 1 (100) 0 (0) 0 (0) 0 (0)
Total 377 293 (77.7) 45 (11.9) 23 (6.1) 16 (4.2)
Table 1 summarises bacterial pathogens identified in this study. Where more than one subtypes identified, collectively they were named
as species (spp) of that genus to accommodate all groups of bacteria in a single table.
© 2017 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 457
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arriving to the hospital (Table 1). Drugs that were com-
monly used were ceftriaxone (n = 173, 46.2%), metron-
idazole (n = 147, 39.4%), cloxacillin (n = 64, 17.1%),
ciprofloxacin (n = 25, 6.6%) and co-trimoxazole (n = 21,
5.5%).
Generally, there was high antimicrobial resistance in
bacterial isolates in this study; Proteus spp, Klebsiella spp
and E. coli exhibited relatively high resistance to all drugs
tested among Gram-negative isolates. Ampicillin resistance
was frequent among Klebsiella spp (n = 24, 92.3%), Pro-
teus spp (n = 21, 75%) and E. coli (n = 13, 68.4%). Other
bacterial spp such as Enterobacter cloacae, Acinetobacter
baumannii, Serratia spp, Morganella morganii and Provi-
dentia spp were resistant by 100% to ampicillin. Resis-
tance of Proteus spp, Klebsiella spp and E. coli to
cefazolin was (n = 23, 82.1%), (n = 16, 61.5%) and
(n = 11, 57.9%), respectively, with all other spp at 100%
resistance. Resistance to third-generation cephalosporins
(ceftriaxone and ceftazidime) was as well observed for
Klebsiella spp (n = 14, 53.8% and n = 12, 46.2%) and
E. coli (n = 8, 42.1% and n = 7, 36.8%), Table 5a.
Among the Gram-positive isolates, S. aureus was the only
species, which demonstrated detectable resistance to peni-
cillin (n = 22, 100%), erythromycin (n = 11, 50%),
trimethoprim–sulfamethoxazole (n = 10, 45.5%), as well
as cefoxitin (n = 6, 27.3%). All S. aureus in this study
were sensitive to vancomycin (refer to Table 5b). Table 5c
summarises the susceptibility pattern of the six cefoxitin-
resistant S. aureus and 16 cefoxitin-susceptible S. aureus.
Resistance of cefoxitin-resistant S. aureus to other drugs
such as erythromycin, penicillin and trimethoprim–sulfa-
methoxazole was 100%, while none were resistant to van-
comycin and chloramphenicol. All cefoxitin-susceptible
S. aureus isolates were resistant to penicillin (100%), six
(37.5%) to erythromycin, five (31.3%) to trimethoprim–
sulfamethoxazole and one (6.3%) to chloramphenicol.
None were resistant to vancomycin.
Discussion
Culture results
KCMC is a referral hospital serving approximately 11
million people in the northern zone of Tanzania. We
conducted a 2-year study from August 2013 to August
2015 to determine the pattern of bacterial pathogens
associated with different health conditions among
patients who were admitted at medical and surgical
departments in this hospital.
The culture results revealed a higher positive growth
rate on wound swab specimens (n = 180, 72.3%), com-
pared to others. Both Gram-negative and positive species
were observed. Our findings are in agreement with other
studies in Africa where wound infections tend to manifest
with a variety of bacterial pathogens [23, 24]. This is
explained by the complexity of wound specimens that
will tend to have a variety of bacterial pathogens,
depending on the way wounds were acquired. Wounds
acquired from a community environment will have more
diverse organisms than hospital-acquired wounds [25,
Table 3 Health conditions and commonly isolated bacterial species
Health condition
Staphylococcus
aureus, n (%)
Klebsiella
spp, n (%)
Proteus spp,
n (%)
Escherichia
coli, n (%)
Pseudomonas
spp, n (%)
Burn wound 6 (17.1) 6 (14.6) 10 (20.4) 2 (4.5) 8 (20)
Motor traffic wound 3 (8.6) 1 (2.4) 6 (12.2) 1 (2.3) 1 (2.5)
Post-surgical wound 2 (5.7) 6 (14.6) 2 (4.1) 3 (6.8) 2 (5)
Diabetic wound 5 (14.3) 7 (17.1) 15 (30.6) 8 (18.2) 8 (20)
Septic wound 20 (57.1) 21 (51.2) 37 (75.5) 24 (54.5) 31 (77.5)
*Other wound 11 (31.4) 6 (14.6) 13 (26.5) 9 (20.5) 17 (42.5)
Diarrhoea 1 (2.9) 1 (2.4) 1 (2) 5 (11.4) 0 (0)
Pneumonia 1 (2.9) 3 (7.3) 0 (0) 4 (9.1) 0 (0)
Septicemia 0 (0) 2 (4.9) 3 (6.1) 1 (2.3) 2 (5)
Malaria 1 (2.9) 0 (0) 1 (2) 0 (0) 1 (2.5)
Cancer 4 (11.4) 4 (9.8) 2 (4.1) 4 (9.1) 5 (12.5)
Diabetes 9 (25.7) 10 (24.4) 18 (36.7) 13 (29.5) 8 (20)
HIV 3 (8.6) 4 (9.8) 3 (6.1) 6 (13.6) 1 (2.5)
TB 1 (2.9) 1 (2.4) 0 (0) 3 (6.8) 1 (2.5)
TB tuberculosis. HIV-Human immunodeficiency virus. NB: Percentages were obtained by cross tabulation of each comorbidity and
isolate. S. aureus N = 35, Klebsiella spp N = 41, Proteus spp N = 49, E. coli N = 44, Pseudomonas spp N = 40.
*Wound due to animal bite, gunshot.
458 © 2017 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd.
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26]. In our study, there were few positive blood speci-
mens (n = 15, 6%) on culture, a finding which is in
agreement with other studies that showed a low positive
growth of blood cultures [27]. Possibly this is because
most septicemia cases we tested were not due to bacterial
infections, a finding that has been reported from other
studies in Tanzania [28]. The use of antibiotic prior to
coming to the hospital, which hinders the detection of
susceptible organisms [29], may be another reason. This
is a practice which is very common in Tanzania and
other developing countries [30–32]. KCMC being a ter-
tiary care hospital receives patients referred from health
facilities in Kilimanjaro region and other parts of Tanza-
nia. The majority of these patients have been treated with
antibiotics in the referring hospital. However, the patients
could also have self-medicated as antibiotics are easily
available and policies to control improper use of antibi-
otics are non-existent in Tanzania, as in other developing
countries [30, 32–35].
Bacterial spectrum
The bacterial spectrum observed from this study showed a
high diversity of Gram-negative bacilli such as Proteus spp
(12.7%), E. coli (11.7%), Pseudomonas spp (10.6%) and
Klebsiella spp (10.1%), with Staphylococcus aureus (9.3%)
being the predominant Gram-positive isolate. The majority
of these Gram-negative bacilli were from wound infections
rather than from other disease conditions. This predomi-
nantly Gram-negative infection pattern, as also observed in
other studies [24, 36, 37], is different from that most com-
monly reported fromWestern Europe and North America
[38, 39]. The reasons for this are not entirely known, but
recent studies have also shown that higher temperatures are
correlated with increased numbers of infections caused by
Gram-negative bacterial species [40]. Our results do how-
ever emphasise that we cannot use knowledge obtained in
Western Europe and North America directly for clinical care
and empirical treatment in sub-Saharan Africa.
Infection pattern
Like any other resource-constrained countries, Tanzania
is still experiencing the burden of infectious diseases. In
the current study, we observed presence of wound infec-
tions (n = 263, 45.9%), septicemia (n = 46, 8.03%),
diarrhoea (n = 20, 3.5%), HIV (n = 81, 14.1%), and
tuberculosis (n = 60, 10.5%) and many other respiratory
infections. As also indicated in other studies [13, 41],
these diseases are still health challenges in low-income
countries. We also recognised the presence of non-
communicable diseases such as cancer (n = 52, 9.1%)
and diabetes (n = 122, 21.3%). This suggests co-existence
of communicable and non-communicable diseases in low-
income countries as has been indicated in other studies
[42, 43]. The increase of diabetes in Tanzania may be the
effect of little knowledge about the risk factors associated
with the disease [4], which may be related to the majority
(n = 339, 59.2%) of the participants having only primary
level education. There was no relationship between the
most frequently isolated bacteria and conditions like dia-
betes and cancer. However, a non-statistically significant
association between diabetes and Proteus spp (19%) and
E. coli (14%) (P = 0.07) was observed. The finding was
more or less the same with HIV status. It was noted that
prevalence of Proteus spp (16%) and Pseudomonas spp
(13%) was higher in wound infections than in those with
no wound infection (9% and 6%, respectively), and the
difference was statistically significant (P = 00.3). This is
in agreement with other studies [25] despite the fact that
the design of the studies was different. Again we can gen-
erally attest that aetiology of a wound infection is broad,
depending on environment and nature of the wound.
Antimicrobial susceptibility testing
Proper identification and determination of antimicrobial
resistance of the bacterial pathogens is crucial to help
physicians to provide proper treatment promptly. The
advancement in pharmaceutical industries has lead to dis-
coveries of many antibiotics, which has facilitated physi-
cians’ efforts into providing quality effective medical
care. Despite of this increase, prudent use is essential in
controlling antimicrobial resistance, which has now
become one of the major challenges for medical progress.
The current study demonstrated that a majority (n = 412,
71.9%) of patients had sought treatment prior to coming
to the hospital. It is likely these patients received antibi-
otics during their previous treatment. The most fre-
quently used drugs were ceftriaxone (46.2%),
metronidazole (39.4%), cloxacillin (17.1%), ciprofloxa-
cin (6.6%) and co-trimoxazole (5.5%). Along with this,
the observed resistance patterns of Gram-negative bacte-
rial isolates tested on drugs such as amoxicillin-clavulanic
acid ampicillin, gentamicin, trimethoprim-sulfamethoxa-
zole and chloramphenicol were relatively high in ampi-
cillin (82.4%) and trimethoprim-sulfamethoxazole
(60%), and below 50% in the rest. This is probably due
to the fact that these drugs are used in Tanzania as first-
line antibiotics in treatment of gastrointestinal diseases,
respiratory diseases, obstetrical/gynaecological, cardiovas-
cular and nervous system diseases [44]. Their easy avail-
ability from hospitals causes these drugs to be commonly
used for treatment by medical practitioners as well as for
© 2017 The Authors. Tropical Medicine & International Health Published by John Wiley & Sons Ltd. 461
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self-medication, factors which play a great role in drug
resistance [33, 34, 45]. The finding is in agreement with
other two studies in Tanzania which indicated resistance
of E. coli and Klebsiella to trimethoprim-sulfamethoxa-
zole, ampicillin, amoxicillin–clavulanic acid and gentam-
icin (100%, 96%, 88%, 60%) and (85%, 95%, 70%,
70%), respectively [46, 47]. Resistance ranging from
9.1% to 78% also has been noted to ciprofloxacin and
nalidixic acid. These are categorised as second-line drugs
in Tanzania, yet they show a high frequency of resis-
tance. As ceftriaxone is a third-generation cephalosporin,
we expected its use to be controlled, yet it was the most
used. Moreover, convincing percentages of resistant
strains of E. coli and Klebsiella to first and third-genera-
tions of cephalosporins have been broadly noted, ranging
from 36.8% to 61.5%. This finding suggests existence of
extended spectrum beta lactamase (ESBL) bacteria, as has
been addressed in other studies in Tanzania [23] where
64.3% of E. coli and 80% of Klebsiella pneumoniae
were ESBL producers. The presence of ESBL producers
reduces treatment options, resulting in higher morbidity
and mortality due to severe infections and sepsis.
Staphylococcus aureus was the predominant spp among
Gram-positive isolates. It accounted for 6 (27.3%) of the
observed resistances to cefoxitin and other antibiotics
such as erythromycin, trimethoprim–sulfamethoxazole
and penicillin G, a characteristic that we would postulate
to indicate methicillin-resistant Staphylococcus (MRSA)
clones, as has been suggested in other studies [48].
Conclusion
The study has revealed a wide range of causative agents,
with an alarming rate of resistance to the commonly used
antimicrobial agents. Furthermore, the bacterial spectrum
differs from those observed in high-income countries. This
highlights the imperative of regular generation of data on
aetiological agents and their antimicrobial susceptibility
patterns especially in infectious disease endemic settings.
The key steps would be to ensure the diagnostic capacity at
a sufficient number of sites and routine exchange, compar-
ison, analysis and reporting of data. As the minimum, sen-
tinel sites (hospitals) across the country and region should
report on a representative subset of bacterial species and
their susceptibility to drugs at least once a year. A central
organising body should collate the data and report to all
relevant national and international stakeholders [49].
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